AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sze, G
Right arrow Articles by Deck, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sze, G
Right arrow Articles by Deck, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 151, Issue 6, 1193-1204
Copyright © 1988 by American Roentgen Ray Society


Articles

Intramedullary disease of the spine: diagnosis using gadolinium-DTPA-enhanced MR imaging

G Sze, G Krol, RD Zimmerman, and MD Deck

Department of Medical Imaging, Memorial Sloan-Kettering Cancer Center, New York, NY.

Twenty-six patients with suspected lesions of the spinal cord were studied before and after administration of gadolinium-DTPA to assess whether contrast enhancement was useful in the MR evaluation of intramedullary disease. Nine patients had primary tumors, six had benign syringes, three had multiple sclerosis with cord involvement, three had thrombosed vascular malformations, three had probable intramedullary metastasis, and two were normal. Although all lesions were detected on noncontrast MR scans, gadolinium-DTPA was of great help in their delineation and characterization. Specifically, contrast material may be able (1) to localize tumor nidus and separate it from edema, in cases of hemangioblastomas and metastases; (2) to suggest regions of more active tumors, in cases of glioma, for surgical biopsy or removal; (3) to differentiate benign or reactive processes from neoplastic lesions, such as reactive cyst from tumor cyst or hematoma due to thrombosed malformation from tumor hemorrhage; and (4) possibly to differentiate active from inactive lesions, for example, in multiple sclerosis. Because of these advantages, gadolinium-DTPA probably will often be used routinely when intramedullary lesions are detected on noncontrast MR scans.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
D.J. Seidenwurm and for the Expert Panel on Neurologic Imaging
Myelopathy
AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 1032 - 1034.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
K. K. Koeller, R. S. Rosenblum, and A. L. Morrison
Neoplasms of the Spinal Cord and Filum Terminale: Radiologic-Pathologic Correlation
RadioGraphics, November 1, 2000; 20(6): 1721 - 1749.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. Breslau, J. G. Jarvik, D. R. Haynor, W. T. Longstreth Jr, D. L. Kent, and K. R. Maravilla
MR Contrast Media in Neuroimaging: A Critical Review of the Literature
AJNR Am. J. Neuroradiol., April 1, 1999; 20(4): 670 - 675.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Roentgen Ray Society.